Tuesday, December 12, 2017 5:04:02 PM
Purchased 50% of 265 acres in Wolf’s Creek, Oregon. The company also entered into an agreement to buy 50% ownership in Groovy Groves, LLC by buying out
partner John C. Miller for 10,000,000 shares of FutureLand Corp’s common stock
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12412325
Item 8.01 Other Events.
On Nov. 15, 2016 FutureLand Oregon, LLC entered into an agreement with HSPendleton, LLC and John C. Miller of Groovy Groves, LLC. The company
purchased 50% of 265 acres in Wolf’s Creek, Oregon. The company also entered into an agreement to buy 50% ownership in Groovy Groves, LLC by buying out
partner John C. Miller for 10,000,000 shares of FutureLand Corp’s common stock. The deal was to be completed upon approval from the OLCC on the transfer of
license to FutureLand Oregon, LLC. from John C. Miller. The process has taken longer than expected due to many delays by OLCC. But now all the requisite
paperwork is completed and submitted for final approval with the OLCC and we are simply waiting on approval, which we believe is imminent.
The harvest for Groovy Groves, LLC was nearly 400lbs this year and is currently being trimmed, dried, cured and will go out for testing next month with sales
expected to be made some time in January 2018. Although we expected quite a bit more product, adjustments are being made to heavily increase yields for next
year. Upon getting the transfer of license, Groovy Groves LLC will apply for a renewal that will include a plan to get a hybrid Tier 2 license with 5,000 square feet
of indoor and 20,000 square feet of outdoor. This will allow us to grow year-round. Ultimately, everything may switch to indoor by the following year, but this is
the current plan. With the way the laws are written right now we should be able to use the same footprint we currently have for the 20,000 square feet of outdoor
and at least double the number of plants we had this last year. Additionally, we should be able to get multiple harvests in the indoor facilities in the coming year
and are prepared to make several modifications which should see 10X more product in 2018.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM